Glucosamine sulfate capsule formulation through domestic product consistency evaluation, so the drug also need to be revised in accordance with the criteria and methods for final approval of the drug, it is carried out as change.
Glucosamine sulfate capsule product has passed the domestic consistency evaluation, so the API should also be revised according to the final approval standard and method of the drug, so the above changes should be made.<br>